{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:08:50Z","timestamp":1773515330234,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aims to analyze the clinical characteristics of pediatric acute lymphoblastic leukemia (ALL) complicated by pneumonia and the risk factors of severe cases to preliminarily construct a prediction model for ALL complicated by severe pneumonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analysis was carried out on the clinical data of children diagnosed with ALL complicated by pneumonia hospitalized at the Department of Pediatrics of the Affiliated Hospital of Southwest Medical University between January 2013 and December 2020. The risk factors of severe ALL complicated by pneumonia were investigated with logistic regression analysis, and the risk prediction model was constructed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 116 cases of pediatric ALL complicated by pneumonia were analyzed. There were 71 cases of mild pneumonia and 45 cases of severe pneumonia. The main clinical manifestations were cough in 112 cases and fever in 109. Pathogens were detected in 23 cases. Multiple regression factor analysis indicated that the use of hormones (OR 4.001, 95% CI: 1.505\u201310.632), neutropenia or agranulocytosis (OR 7.472, 95% CI: 2.710\u201320.602), hemoglobin (Hb) &amp;lt; 90 g\/L (OR 3.270, 95% CI: 1.256~8.516), and C-reactive protein (CRP) &amp;gt;15 mg\/L (OR 3.253, 95% CI: 1.209~8.751) were independent risk factors that were associated with severe pneumonia. Logistic regression was used to establish the risk prediction model of ALL with severe pneumonia. The <jats:italic>p<\/jats:italic>-value was 0.659. The area under the receiver operating characteristic curve was 0.851, and the sensitivity and specificity were 84.4 and 71.8%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The development of severe pneumonia may be affected by the use of hormones, neutropenia or agranulocytosis, Hb &amp;lt; 90 g\/L, and CRP &amp;gt; 15 mg\/L. The prediction model based on the risk factors is effective, which can provide a reference for the clinical evaluation of acute lymphoblastic leukemia with severe pneumonia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.813638","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T06:45:18Z","timestamp":1651819518000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Features and Risk Factors of Severe Pneumonia in Children With Acute Lymphoblastic Leukemia"],"prefix":"10.3389","volume":"10","author":[{"given":"Chun-yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S2352-4642(18)30066-X","article-title":"Global efforts toward the cure of childhood acute lymphoblastic leukemia","volume":"2","author":"Pui","year":"2018","journal-title":"Lancet Child AdolescHealth."},{"key":"B2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/annonc\/mdw557","article-title":"Infection-related complications during treatment for childhood acute lymphoblastic leukemia","volume":"28","author":"Inaba","year":"2017","journal-title":"Ann Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e07209","DOI":"10.1016\/j.heliyon.2021.e07209","article-title":"Hospital acquired pneumonia risk factors in children with Acute Lymphoblastic Leukemia on chemotherapy","volume":"7","author":"Mairuhu","year":"2021","journal-title":"Heliyon."},{"key":"B4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/08880010802106564","article-title":"Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes","volume":"25","author":"Bakhshi","year":"2008","journal-title":"Pediatr Hematol Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.14740\/jh751","article-title":"Treatment-related mortality from infectious complications in an acute leukemia clinic","volume":"9","author":"Torres-Flores","year":"2020","journal-title":"J Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3760\/cma.j.issn.0578-1310.2014.09.001","article-title":"[Recommendations for diagnosis and treatment of childhood acute lymphoblastic leukemia (Fourth Revision)]","volume":"52","year":"2014","journal-title":"Chin J Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3760\/cma.j.issn.1674-2397.2019.01.002","article-title":"Guideline for diagnosis and treatment of community-acquired pneumonia in Children (2019 version)","volume":"12","year":"2019","journal-title":"Chin J Clin Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"Torres","year":"2021","journal-title":"Nat Rev Dis Primers."},{"key":"B9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.mcna.2018.12.008","article-title":"Community-acquired pneumonia and hospital-acquired pneumonia","volume":"103","author":"Lanks","year":"2019","journal-title":"Med Clin North Am."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2014-03-560847","article-title":"Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003","volume":"124","author":"O'Connor","year":"2014","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0065-230X(08)00406-5","article-title":"Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis","volume":"101","author":"Sionov","year":"2008","journal-title":"Adv Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ejca.2020.09.032","article-title":"How to manage patients with corticosteroids in oncology in the era of immunotherapy?","volume":"141","author":"Aldea","year":"2020","journal-title":"Eur J Cancer."},{"key":"B13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1378\/chest.123.2.488","article-title":"Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response","volume":"123","author":"Agust\u00ed","year":"2003","journal-title":"Chest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/jmv.24930","article-title":"Influenza in patients with hematological malignancies: experience at two comprehensive cancer centers","volume":"90","author":"Vilar-Compte","year":"2018","journal-title":"J Med Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3760\/cma.j.issn.0376-2491.2018.10.005","article-title":"Clinical characteristics and prognosis of long-term glucocorticoid users with community-acquired pneumonia","volume":"98","author":"Li","year":"2018","journal-title":"Natl Med J China"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.idh.2019.08.006","article-title":"Bloodstream infections in neutropenic patients with haematological malignancies","volume":"25","author":"Carvalho","year":"2020","journal-title":"Infect Dis Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1470-2045(08)70255-9","article-title":"Lung infections after cancer chemotherapy","volume":"9","author":"Vento","year":"2008","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00431-015-2525-5","article-title":"Bloodstream infection in paediatric cancer centres\u2013leukaemia and relapsed malignancies are independent risk factors","volume":"174","author":"Ammann","year":"2015","journal-title":"Eur J Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12199-020-00931-z","article-title":"Anemia as a risk factor for tuberculosis: a systematic review and meta-analysis","volume":"26","author":"Gelaw","year":"2021","journal-title":"Environ Health Prev Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e20193728","DOI":"10.1542\/peds.2019-3728","article-title":"Biomarkers and disease severity in children with community-acquired pneumonia","volume":"145","author":"Florin","year":"2020","journal-title":"Pediatrics."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.3892\/ol.2018.7731","article-title":"Risk factors and coping strategies of severe community-acquired pneumonia in chemotherapy induction period of acute leukemia","volume":"15","author":"Li","year":"2018","journal-title":"Oncol Lett."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.813638\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T06:45:20Z","timestamp":1651819520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.813638\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":22,"alternative-id":["10.3389\/fped.2022.813638"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.813638","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"article-number":"813638"}}